Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MBF-015 by Medibiofarma for Huntington Disease: Likelihood of Approval
MBF-015 is under clinical development by Medibiofarma and currently in Phase II for Huntington Disease. According to GlobalData, Phase II...
MBF-015 by Medibiofarma for Huntington Disease: Likelihood of Approval
MBF-015 is under clinical development by Medibiofarma and currently in Phase II for Huntington Disease. According to GlobalData, Phase II...
MBF-015 by Medibiofarma for Alzheimer's Disease: Likelihood of Approval
MBF-015 is under clinical development by Medibiofarma and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase I...